Mylan’s Generic EpiPen Cuts Patient Cost in Half

What's Hot

The Most Sinful City in the U.S. Is … (Hint: It’s Not Vegas)Family

How a Mexican Tariff Will Boost the Cost of 6 Common PurchasesFamily

This Free Software Brings Old Laptops Back to LifeMore

How to Protect Yourself From the ‘Can You Hear Me?’ Phone ScamFamily

Report: Walmart to Begin Selling CarsCars

Where to Sell Your Stuff for Top DollarAround The House

Is Your TV Tracking You? Here’s How to Tell — and Prevent ItAround The House

11 Staging Tips to Help You Get Top Dollar When Selling Your HomeAround The House

21 Restaurants Offering Free Food Right NowSaving Money

20 Simple Hacks to Make Your Stuff Last LongerAround The House

4 Car Insurers That Might Raise Rates Even When the Accident Wasn’t Your FaultCars

How to Invest If Trump Kills the ‘Fiduciary Rule’Grow

12 Surprising Ways to Wreck Your Credit ScoreBorrow

9 Secret Ways to Use Toothpaste That Will Make You SmileAround The House

The 2 Types of Music That Most Improve Dog BehaviorFamily

The drug company spent much of the year facing a torrent of criticism over the high price of its life-saving allergy medication.

Here is some good news for those who suffer from life-threatening allergies: Drugmaker Mylan is launching a half-priced generic version of its popular, — but prohibitively expensive — EpiPen.

Mylan made headlines this fall, when it was reported the company had increased the price of the EpiPen — a medical device that can stop a potentially deadly reaction to a bee sting or some types of consumed food — by a jaw-dropping 400 percent between 2008 and 2016. The price jump triggered a federal probe and widespread criticism from consumers.

Mylan purchased EpiPen from another drugmaker in 2007, when the allergy devices had a wholesale price of roughly $57 each and sold in pharmacies for about $100.

The EpiPens contain about $1 worth of epinephrine. The price for a two-pack of EpiPens today tops $600. According to the Associated Press, Mylan says it will charge $300 for a generic two-pack of the life-saving epinephrine devices.

Although it’s not known how much consumers will actually save by purchasing the generic pens — rather than the brand name EpiPens — the generic devices are a clear boon to Mylan. The AP explains:

The potential [consumer] cost savings will depend in part on a patient’s insurance coverage and qualifications for discount and assistance programs that the drugmaker also provides.
For Mylan, the benefit from its long-promised generic is more certain: It is expected to generate millions of dollars in revenue while also protecting the drugmaker’s market share against competition.

The generic EpiPens should hit pharmacy store shelves this week, CBS reports.

For another alternative to EpiPens, check out “$30 ‘EpiPencil’ Is DIY Alternative to EpiPen.”

What do you think about Mylan’s generic alternative to the EpiPen? Sound off below or on Facebook.

Stacy Johnson

It's not the usual blah, blah, blah

I know... every site you visit wants you to subscribe to their newsletter. But our news and advice is actually worth reading! For 25 years, I've been making people richer without making their eyes glaze over. You'll be glad you did. I guarantee it!


Read Next: 8 Ways to Get Your FICO Score for Free

Check Out Our Hottest Deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 1,791 more deals!